Early, aggressive therapy for rheumatoid arthritis: concerns, descriptions, and estimate of outcome.

[1]  L. Russel Cecil,et al.  Textbook of Medicine , 1932 .

[2]  R. Cecil,et al.  GOLD SALTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS; ASTUDY OF 245 CASES , 1942 .

[3]  V. Wright.  Some observations on diurnal variation of grip. , 1959, Clinical science.

[4]  J. Lansbury,et al.  Statistical study of variation in systemic and articular indexes. , 1962, Arthritis and rheumatism.

[5]  J. Duthie,et al.  Course and Prognosis in Rheumatoid Arthritis , 1964, Annals of the rheumatic diseases.

[6]  D. Mainland.  A Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritis , 1965 .

[7]  R. Winchester,et al.  Observations on the eosinophilia of certain patients with rheumatoid arthritis. , 1971, Arthritis and rheumatism.

[8]  B. McConkey,et al.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants. , 1972, The Quarterly journal of medicine.

[9]  M. Jayson,et al.  Onset, Early Stages, and Prognosis of Rheumatoid Arthritis: A Clinical Study of 100 Patients with 11-year Follow-up , 1973, British medical journal.

[10]  E. Huskisson.  Measurement of pain. , 1974, Lancet.

[11]  M. Corbett,et al.  Prognostic value of early features in rheumatoid disease. , 1976, British medical journal.

[12]  R. Hutchinson,et al.  Thrombocytosis in rheumatoid arthritis. , 1976, Annals of the rheumatic diseases.

[13]  H. Isomäki,et al.  Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. , 1977, Scandinavian journal of rheumatology.

[14]  E. Huskisson,et al.  Accuracy of subjective measurements made with or without previous scores: an important source of error in serial measurement of subjective states. , 1979, Annals of the rheumatic diseases.

[15]  A. Masi,et al.  Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients. , 1979, The American journal of medicine.

[16]  B. McConkey,et al.  Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis. , 1979, Annals of the rheumatic diseases.

[17]  V. Wright,et al.  Plasma viscosity-a new appraisal of its use as an index of disease activity in rheumatoid arthritis , 2022 .

[18]  P Tugwell,et al.  Preference for endpoint measures in clinical trials: results of structured workshops. , 1982, The Journal of rheumatology.

[19]  R. Pope,et al.  Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors. , 1983, The Journal of rheumatology.

[20]  H. Moldofsky,et al.  Alpha EEG sleep and morning symptoms in rheumatoid arthritis. , 1983, The Journal of rheumatology.

[21]  P. Bacon,et al.  Progression of radiological changes in rheumatoid arthritis. , 1984, Annals of the rheumatic diseases.

[22]  G. Langley,et al.  Problems associated with pain measurement in arthritis: comparison of the visual analogue and verbal rating scales. , 1984, Clinical and experimental rheumatology.

[23]  T. Saxne,et al.  Factors related to the progression of joint destruction in rheumatoid arthritis. , 1984, Scandinavian journal of rheumatology.

[24]  W. O'Fallon,et al.  Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. , 1984, Arthritis and rheumatism.

[25]  T. Pullar,et al.  Does second-line therapy affect the radiological progression of rheumatoid arthritis? , 1984, Annals of the rheumatic diseases.

[26]  B. McConkey,et al.  Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone. , 1984, Annals of the rheumatic diseases.

[27]  H. Valdimarsson,et al.  Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. , 1984, Annals of the rheumatic diseases.

[28]  T. Pincus,et al.  Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. , 1984, Arthritis and rheumatism.

[29]  M H Liang,et al.  Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. , 1985, Arthritis and rheumatism.

[30]  K. Kaarela.  Prognostic factors and diagnostic criteria in early rheumatoid arthritis. , 1985, Scandinavian journal of rheumatology. Supplement.

[31]  J. Reading,et al.  Reduced joint count indices in the evaluation of rheumatoid arthritis. , 1985, Arthritis and rheumatism.

[32]  P. Tugwell,et al.  Grading of tenderness as a source of interrater error in the Ritchie articular index. , 1985, The Journal of rheumatology.

[33]  J. Fries,et al.  The development of disability in rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[34]  S. Holbeck,et al.  IDENTIFICATION OF HLA-Dw14 GENES IN DR4+ RHEUMATOID ARTHRITIS , 1986, The Lancet.

[35]  P. Dawes,et al.  Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. , 1986, British journal of rheumatology.

[36]  G. Carrera,et al.  Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. , 1986, JAMA.

[37]  P Tugwell,et al.  The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. , 1987, The Journal of rheumatology.

[38]  D. Symmons,et al.  LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS , 1987, The Lancet.

[39]  P. Emery,et al.  Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study. , 1987, British journal of rheumatology.

[40]  P. Dawes,et al.  Combination therapy in rheumatoid arthritis--study design. , 1987, British journal of rheumatology.

[41]  A. Unsworth,et al.  Assessment of stiffness in rheumatology: the use of rating scales. , 1987, British journal of rheumatology.

[42]  T. Medsger,et al.  Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. , 1987, The American journal of medicine.

[43]  V. Wright,et al.  Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis. , 1987, British journal of rheumatology.

[44]  V. Wright,et al.  Lack of objective evidence of stiffness in rheumatoid arthritis. , 1988, Annals of the rheumatic diseases.

[45]  A. Kalla,et al.  Clinical assessment of disease activity in rheumatoid arthritis: evaluation of a functional test. , 1988, Annals of the rheumatic diseases.

[46]  T. Möttönen,et al.  Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. , 1988, Annals of the rheumatic diseases.

[47]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[48]  D. Heijde,et al.  Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. , 1988 .

[49]  L E Kazis,et al.  The stability of health status in rheumatoid arthritis: a five-year study of patients with established disease. , 1988, American journal of public health.

[50]  T. Pincus,et al.  Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. , 1988, Journal of clinical epidemiology.

[51]  T. Pincus,et al.  Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. , 1989, The Journal of rheumatology.

[52]  P. Bacon,et al.  Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study. , 1989, British journal of rheumatology.

[53]  I. Kushner.  Does aggressive therapy of rheumatoid arthritis affect outcome? , 1989, The Journal of rheumatology.

[54]  C. Watts,et al.  Combination methotrexate and sulfasalazine in the management of rheumatoid arthritis: case observations. , 1989, Arthritis and rheumatism.

[55]  P. Venables,et al.  Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. , 1989, Annals of the rheumatic diseases.

[56]  D. Stage,et al.  HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. , 1989, Arthritis and rheumatism.

[57]  M. Mahowald,et al.  Sleep fragmentation in rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[58]  D. Felson,et al.  Which traditional measures should be used in rheumatoid arthritis clinical trials? , 1989, Arthritis and rheumatism.

[59]  T. Spector,et al.  What should we hope to achieve when treating rheumatoid arthritis? , 1989, Annals of the rheumatic diseases.

[60]  L. A. Healey,et al.  Remodeling the pyramid--a concept whose time has come. , 1989, The Journal of rheumatology.

[61]  Hess Ev,et al.  Remodeling the pyramid--a concept whose time has not yet come. , 1989 .

[62]  T. Pincus,et al.  A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[63]  P. Sarzi puttini,et al.  Clinical, laboratory and radiographic features in early rheumatoid arthritis. , 1990, The Journal of rheumatology.

[64]  M. A. van 't Hof,et al.  Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. , 1990, Annals of the rheumatic diseases.

[65]  J. Fries,et al.  Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. , 1990, The Journal of rheumatology. Supplement.

[66]  L. V. D. van de Putte,et al.  Risk factors of second-line antirheumatic drugs in rheumatoid arthritis. , 1990, Seminars in arthritis and rheumatism.

[67]  Klippel Jh.  Winning the battle, losing the war? Another editorial about rheumatoid arthritis. , 1990 .

[68]  L. Kazis,et al.  Health status as a predictor of mortality in rheumatoid arthritis: a five-year study. , 1990, The Journal of rheumatology.

[69]  D. Felson,et al.  The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. , 1990, Arthritis and rheumatism.

[70]  B. McConkey,et al.  Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response. , 1990, The Journal of rheumatology.

[71]  David T. Felson,et al.  THE COMPARATIVE EFFICACY AND TOXICITY OF SECOND LINE DRUGS IN RHEUMATOID ARTHRITIS , 1990 .

[72]  F. Wolfe.  50 years of antirheumatic therapy: the prognosis of rheumatoid arthritis. , 1990, The Journal of rheumatology. Supplement.

[73]  A. Silman,et al.  Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. , 1990, Annals of the rheumatic diseases.

[74]  K. Federlin,et al.  Adrenal secretion of cortisol in patients with rheumatoid arthritis. , 1990, The Journal of rheumatology.

[75]  J. Dacre,et al.  Can we develop simple response criteria for slow acting antirheumatic drugs? , 1990, Annals of the rheumatic diseases.

[76]  J. Fries,et al.  A toxicity index for comparison of side effects among different drugs. , 1990, Arthritis and rheumatism.

[77]  H. Paulus,et al.  The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[78]  E. Devries,et al.  Synergistic and additive effects of disease modifying anti-rheumatic drugs combined with chloroquine on the mitogen-driven stimulation of mononuclear cells. , 1990 .

[79]  F. Epstein,et al.  Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.

[80]  M. Guttadauria,et al.  Methotrexate in Rheumatoid Arthritis: Impact on Quality of Life Assessed by Traditional Standard-Item and Individualized Patient Preference Health Status Questionnaires , 1990 .

[81]  R. Weisbart,et al.  Rheumatoid factors specific for active rheumatoid arthritis. , 1990, Annals of the rheumatic diseases.

[82]  T. Pullar.  Combination therapy in rheumatoid arthritis. , 1991, British journal of rheumatology.

[83]  J. Fries,et al.  Mortality predictors among 263 patients with rheumatoid arthritis. , 1991, The Journal of rheumatology.

[84]  P. Dawes,et al.  Should disease-modifying agents be used in mild rheumatoid arthritis? , 1991, British journal of rheumatology.

[85]  J. Fries,et al.  Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. , 1991, The Journal of rheumatology.

[86]  M. Ramsden,et al.  Long acting drug combinations in rheumatoid arthritis: a formal overview. , 1991, The Journal of rheumatology.

[87]  T. Spector,et al.  Comparison of four articular indices for use in clinical trials in rheumatoid arthritis: patient, order and observer variation. , 1991, The Journal of rheumatology.

[88]  J. Clough,et al.  Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment. , 1991, Seminars in arthritis and rheumatism.

[89]  F. Wolfe,et al.  The assessment and prediction of functional disability in rheumatoid arthritis. , 1991, The Journal of rheumatology.

[90]  R. Willkens.  Prognostic staging for therapy of rheumatoid arthritis. , 1991, Seminars in arthritis and rheumatism.

[91]  F. Wolfe,et al.  Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis. , 1991, The Journal of rheumatology.

[92]  A. Peretz,et al.  Reliability and reproducibility of visual analogue scale and numeric rating scale for therapeutic evaluation of pain in rheumatic patients. , 1991, The Journal of rheumatology.

[93]  N. Bellamy,et al.  Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. , 1991, Annals of the rheumatic diseases.

[94]  L. Kazis,et al.  The clinical and health status of patients with recent-onset rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[95]  J. Symons,et al.  Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. , 1991, Clinical immunology and immunopathology.

[96]  A. Masi,et al.  Early therapy with aurothioglucose and low dose triamcinolone in rheumatoid arthritis ra results of a longitudinal study , 1991 .

[97]  M. Weinblatt,et al.  Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. , 1992, Arthritis and rheumatism.

[98]  F. Guillemin,et al.  Functional disability in rheumatoid arthritis: two different models in early and established disease. , 1992, The Journal of rheumatology.